Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Dishman Carbogen Amcis Ltd. ( (IN:DCAL) ) is now available.
Dishman Carbogen Amcis Limited has announced the allotment of 5,000 rated, listed, senior, secured, redeemable, taxable non-convertible debentures, each with a face value of INR 1,00,000, totaling INR 50 crore. This strategic financial move, approved by the company’s board, is aimed at raising capital through private placement, potentially enhancing the company’s financial stability and market positioning.
More about Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and intermediates. The company serves a global market, providing services and products to pharmaceutical companies.
YTD Price Performance: -20.86%
Average Trading Volume: 37,773
Current Market Cap: 35.48B INR
See more insights into DCAL stock on TipRanks’ Stock Analysis page.